Plain-English translation of NCT05539014 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows people with newly diagnosed tuberculosis as they receive treatment. Researchers will collect information about your diagnosis, treatment progress, and health outcomes over time to understand how well current tuberculosis treatments work and identify ways to improve care for future patients.
Tuberculosis remains a serious infection worldwide, and doctors need better information about how well treatments work in real-world settings. In France, not enough patients are successfully completing their tuberculosis treatment, and this study aims to track outcomes and find ways to help more people recover.
You likely qualify if…
You likely don't qualify if…
You would be enrolled at Avicenne Hospital or another participating center when you start tuberculosis treatment. Researchers will collect information about your diagnosis, track how your treatment is progressing, and document your health outcomes—likely including check-ins over the course of your treatment and follow-up period. This is not a medication trial; rather, doctors are observing and documenting how you respond to standard tuberculosis treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France